Replies to post #27461 on Anavex Life Sciences Corp (AVXL)

[rebden]

Interesting that he's Australian.

[mixedup]

I don't know of the person who produced those numbers, but there's a lot conflict within them. As long as Missling is running this ship, there won't be more than 100M O/S. The A/S is just 100M, and we're fully diluted around 42M.

100% of people with AD need treatment. Perhaps the folks with severe AD may be too far gone. If 2-73 does what we all hope it appears to do, then market penetration would be significantly greater than 30%. Anyone with even minimal insurance would likely replace standalone donepezil with 2-73 or Anavex PLUS. IMHO.

[raja48185]

looked at the numbers and assumptions he used - very conservative price target and at this point in time it is understandable.

If global consideration is accounted for and potential of pipeline is taken into account, then one could multiply his target by a factor of 3 to 5 easily.

[Maciste]

Stupid question, but what time frame are we talking about 2-5 years?